This content is machine translated Chronic myeloid leukemia (CML) Transcript types, molecular response and biomarkers on the test bench. Chronic myeloid leukemia is a model disease for diagnosis and therapy of neoplastic diseases. The underlying cytogenetic aberration and the multistage progression enable the transfer of molecular cytogenetic findings into…
View Post 4 min This content is machine translated DKK in Berlin - Leukemia treatment Revolution through personalized therapy Knowledge of molecular markers in leukemias could help identify high-risk patients in the future. In addition, there is an opportunity to develop further targeted therapeutic approaches. Some already approved therapeutics…
View Post 5 min This content is machine translated EHA Congress in Madrid Earlier response does not translate into higher overall survival in CML Overall survival of patients with chronic myeloid leukemia cannot be altered by optimizations of imatinib therapy. This is despite the fact that earlier evaluations were able to demonstrate an influence…
View Post 6 min This content is machine translated Chronic myeloid leukemia State of the Art – where are we at CML in 2017? CML patients have a normal life expectancy when treated with Abl-specific kinase inhibitors (TKIs) in chronic phase. Imatinib, dasatinib and nilotinib are approved in the first-line treatment of CML. In…
View Post 3 min This content is machine translated Chronic myeloid leukemia When is it possible to stop therapy? Most patients with CML are dependent on therapy with a tyrosine kinase inhibitor for the rest of their lives. However, there is increasing research into when and in which patients…
View Post 4 min This content is machine translated Chronic myeloid leukemia Diagnostics and therapy of CML – current state of knowledge A lot has happened in the field of chronic myeloid leukemia (CML) in recent years. Response and survival rates have risen sharply, and some patients are even said to be…
View Post 4 min This content is machine translated Hemato-Oncology All hopes lie in targeted therapy What do so-called targeted therapies actually aim at? And what progress has been made in the various hematologic oncologic neoplasms in this regard? At the 21st Symposium Medicine in the…
View Post 4 min This content is machine translated Lung, kidney cancer and chronic myeloid leukemia What does modern clinical practice look like? At the DGHO Congress in Vienna, various aspects in clinical practice in non-small cell lung cancer (NSCLC), renal cell cancer (RCC) and chronic myeloid leukemia were addressed. In particular, the…
View Post 4 min This content is machine translated Hematology New possibilities thanks to targeted therapy At the DGHO congress in Vienna, the focus was on new targeted therapies designed to improve the quality of life of patients with malignant hematologic diseases. In particular, medical advances…
